Gallwitz, B., Böhmer, M., Segiet, T., Mölle, A., Milek, K., Becker, B., . . . Bachmann, O. (2011). Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes: A randomized 26-week study on glycemic control and hypoglycemia. American Diabetes Association.
Chicago Stili AlıntıGallwitz, Baptist, et al. Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes: A Randomized 26-week Study On Glycemic Control and Hypoglycemia. American Diabetes Association, 2011.
MLA AlıntıGallwitz, Baptist, et al. Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes: A Randomized 26-week Study On Glycemic Control and Hypoglycemia. American Diabetes Association, 2011.